Clara cell protein 16
Autor: | Ingo Marzi, Dirk Henrich, Luisa Backhaus, John H. Barker, Emanuel V. Geiger, Sebastian Wutzler, Helmut L. Laurer |
---|---|
Rok vydání: | 2012 |
Předmět: |
Male
medicine.medical_specialty Respiratory complications Thoracic Injuries Acute Lung Injury Enzyme-Linked Immunosorbent Assay Lung injury Critical Care and Intensive Care Medicine Gastroenterology Injury Severity Score Internal medicine Humans Uteroglobin Medicine In patient Respiratory Distress Syndrome Receiver operating characteristic Multiple Trauma business.industry Middle Aged medicine.disease Pneumonia Clara cell protein 16 Immunology Biomarker (medicine) Female Surgery business Biomarkers |
Zdroj: | Journal of Trauma and Acute Care Surgery. 73:838-842 |
ISSN: | 2163-0755 |
DOI: | 10.1097/ta.0b013e31825ac394 |
Popis: | BACKGROUND Clara cell protein 16 (CC16) has recently gained acceptance as a blood biomarker for detecting direct and indirect lung injury. Although the early elevation of CC16 serum levels has been shown to correlate with pulmonary damage in patients with multiple injuries, the subsequent time course of CC16 serum levels has not been investigated in these patients. METHODS Fifty-eight patients with multiple injuries, 32 with severe thoracic injury, and 12 healthy volunteers were enrolled in this study. CC16 serum levels were measured at the time they were admitted to the trauma ward "time 0" and subsequently until day 14 using the enzyme-linked immunosorbent assay technique. The correlation between CC16 serum levels and severe lung injury, onset of nosocomial pneumonia, acute respiratory distress syndrome or acute lung injury, and organ failure was measured. In addition, areas under the receiver operating characteristic curve were calculated (p < 0.05 = significant). RESULTS In patients with lung injury, initial "time 0" median CC16 values were significantly elevated (11.2 ng/mL) compared with patients without severe thoracic injury (6.9 ng/mL) and controls (6.3 ng/mL). The observed elevation in serum CC16 declined to control values within 12 to 24 hours after trauma unless patients secondarily developed pneumonia. In the latter patients, median CC16 serum levels were significantly elevated (14.5 ng/mL) at the onset of pneumonia compared with their levels (7.3 ng/mL) 1 day before. In contrast, no secondary elevation in CC16 serum levels was observed in patients without severe lung injury within the same 24-hour period. The area under the receiver operating characteristic curve for serum CC16 and pneumonia was 0.79 (0.62-0.97; p = 0.0011). CONCLUSION Our results confirm the previously described association between initial elevation in CC16 serum levels and severe thoracic injury in patients with multiple injuries. In addition, we found that the initial elevation in CC16 serum levels declines to control values within the first day after trauma and that a secondary elevation indicates respiratory complications. LEVEL OF EVIDENCE Diagnostic study, level II. |
Databáze: | OpenAIRE |
Externí odkaz: |